期刊
IUBMB LIFE
卷 65, 期 2, 页码 127-133出版社
WILEY
DOI: 10.1002/iub.1109
关键词
amyloid-ss precursor protein; amyloid-beta; cyclic adenosine monophosphate; rolipram; phosphodiesterase; memory; Alzheimer's disease
资金
- Alzheimer's Association
- Fondazione CARIGE
- PRIN [2009M8FKBB_002, 2008N9N9KL_002]
Besides playing a pathogenic role in Alzheimer disease, amyloid-beta peptides are normally produced in low amounts in the brain, and several lines of evidence suggest that they can modulate synaptic plasticity and memory. As cyclic adenosine monophosphate (cAMP) is known to be involved in the same processes and the blockade of its degradation by phosphodiesterase 4 inhibitors has consistently shown beneficial effects on cognition, we investigated the possible correlation between this second messenger and A beta peptides in neuronal N2a cells overexpressing the amyloid-beta precursor protein (APP). We herein report that the elevation of endogenous cAMP by rolipram increased APP protein expression and both its amyloidogenic and nonamyloidogenic processing. The effects of rolipram were reproduced by both the cAMP membrane-permeant analog 8Br-cAMP and the forskolin-induced activation of adenylyl cyclase but were not affected by the PKA inhibitor H-89. Our results demonstrate that, in neuronal cells, APP metabolism is physiologically modulated by cAMP and suggest that this might represent an additional mechanism through which the second messenger could influence memory functions. (c) 2013 IUBMB Life, 65(2)127133, 2013
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据